Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
2(22%)
Results Posted
67%(2 trials)
Terminated
1(11%)

Phase Distribution

Ph not_applicable
4
44%
Ph phase_3
1
11%
Ph phase_4
4
44%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
4(44.4%)
N/ANon-phased studies
4(44.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(3)
Terminated(2)
Other(1)

Detailed Status

Completed3
Recruiting2
Not yet recruiting1
Withdrawn1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (11.1%)
Phase 44 (44.4%)
N/A4 (44.4%)

Trials by Status

recruiting222%
not_yet_recruiting111%
completed333%
withdrawn111%
terminated111%
unknown111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9